First-pass extracted concept

dual-targeted stimuli-responsive liposomes

Candidate: concept label1 source documents3 linked claims

Jump to explainers Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Extracted Explainers

What the tool is doing

Dual-targeted stimuli-responsive liposomes are described as surface-functionalized nanocarriers that can achieve sequential active tumor targeting. They combine targeting behavior with stimulus-modulated release.

Source 1DOI PubMed

Resources required

They require surface functionalization and a stimulus-responsive liposomal design. The abstract indicates that targeting behavior is modulated by the applied stimulus.

Source 1DOI PubMed

What problem it solves

They aim to improve selective delivery to organs, tissues, or cells while enabling controlled release, which may improve efficacy and reduce toxicity.

Source 1DOI PubMed

What it does not solve

The abstract does not specify which dual-targeting ligand combinations work best or how broadly the strategy generalizes across diseases.

Source 1DOI PubMed

Alternatives

The abstract contrasts them with broader intelligent-responsive nanocarriers and with light-responsive liposomes as a highlighted subtopic.

Source 1DOI PubMed

Evidence Snippets

In this review, we highlighted the emerging functional role of light in nanocarriers, with an emphasis on light-responsive liposomes and dual-targeted stimuli-responsive liposomes.

Evidence 1Source 1DOI PubMedprovenance

Supporting Sources

Source 1primary paper2024MoleculesDOI PubMed

1 evidence snippet 3 linked claims Claim 1 Claim 2 Claim 3

Linked Claims

Claim 1application potentialsupports2024Source 1DOI PubMed

Stimuli-modulated targeted nanocarriers can direct cargo to target-specific organs, tissues, or cells and provide on-demand controlled drug release that may enhance therapeutic effectiveness and reduce systemic toxicity.

Quoted textsource-backed

these intelligent-responsive nanocarriers can be directed to different target-specific organs, tissues, or cells and exhibit on-demand controlled drug release that may enhance therapeutic effectiveness and reduce systemic toxicity

Claim 2mechanism overviewsupports2024Source 1DOI PubMed

Smart stimuli-responsive nanocarriers can release cargo in response to specific stimuli.

Quoted textsource-backed

smart, stimuli-responsive nanocarriers that are capable of releasing their cargos in response to specific stimuli

Claim 3targeting strategysupports2024Source 1DOI PubMed

Stimuli-responsive nanocarriers can be surface-functionalized to achieve sequential active tumor targeting modulated by the stimulus.

Quoted textsource-backed

These intelligent-responsive nanocarriers can be further surface-functionalized so as to achieve active tumor targeting in a sequential manner, which can be simply modulated by the stimuli.